Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$492M |
| 2 |
LLL
L3 Technologies, Inc.
LLL
|
+$392M |
| 3 |
Apple
AAPL
|
+$245M |
| 4 |
AGN
Allergan plc
AGN
|
+$238M |
| 5 |
NXP Semiconductors
NXPI
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$568M |
| 2 |
Coty
COTY
|
+$491M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$224M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$211M |
| 5 |
Sysco
SYY
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.43% |
| 2 | Healthcare | 13.06% |
| 3 | Technology | 11.97% |
| 4 | Financials | 10.69% |
| 5 | Consumer Discretionary | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Incyte
INCY
$25.9B
| $1.05M | ﹤0.01% |
12,414
-372,608
| -97% | -$29.9M |
|
|
TTOO
2752
DELISTED
T2 Biosystems, Inc
TTOO
| $1.05M | ﹤0.01% |
+126
| New | +$1.48M |
|
2753
O'Reilly Automotive
ORLY
$71B
| $1.05M | ﹤0.01% |
42,675
-431,265
| -91% | -$10.9M |
|
|
TCF
2754
DELISTED
TCF Financial Corporation
TCF
| $1.05M | ﹤0.01% |
50,561
+6,451
| +15% | +$135K |
|
|
GTS
2755
DELISTED
Triple-S Management Corporation
GTS
| $1.05M | ﹤0.01% |
46,194
+7,763
| +20% | +$176K |
|
2756
Editas Medicine
EDIT
$508M
| $1.04M | ﹤0.01% |
42,225
-84,241
| -67% | -$2.01M |
|
|
SNCR
2757
DELISTED
Synchronoss Technologies
SNCR
| $1.04M | ﹤0.01% |
14,674
-38,763
| -73% | -$2.19M |
|
|
LAIX
2758
DELISTED
LAIX Inc. American Depositary Shares, each representing fourteen Class A Ordinary Shares
LAIX
| $1.04M | ﹤0.01% |
7,117
-240
| -3% | -$35.1K |
|
2759
Pixelworks
PXLW
$41.9M
| $1.04M | ﹤0.01% |
29,452
+5,516
| +23% | +$237K |
|
|
IMGN
2760
CALL
DELISTED
Immunogen Inc
IMGN
| $1.04M | ﹤0.01% |
480,000
-993,400
| -67% | -$2.35M |
|
2761
Entravision Communication
EVC
$745M
| $1.04M | ﹤0.01% |
332,589
+129,983
| +64% | +$395K |
|
2762
HNI Corp
HNI
$3.61B
| $1.04M | ﹤0.01% |
29,328
-9,659
| -25% | -$347K |
|
2763
Seres Therapeutics
MCRB
$49.4M
| $1.04M | ﹤0.01% |
16,093
+1,528
| +10% | +$145K |
|
2764
PUT
AT&T
T
$174B
| $1.03M | ﹤0.01% |
40,912
+19,728
| +93% | +$473K |
|
2765
Metallus
MTUS
$826M
| $1.03M | ﹤0.01% |
127,109
+111,402
| +709% | +$1.01M |
|
|
MORF
2766
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.03M | ﹤0.01% |
+52,000
| New | +$983K |
|
|
BMTC
2767
DELISTED
Bryn Mawr Bank Corp
BMTC
| $1.03M | ﹤0.01% |
27,639
+14,037
| +103% | +$525K |
|
|
TLRA
2768
DELISTED
Telaria, Inc.
TLRA
| $1.03M | ﹤0.01% |
137,068
-355,720
| -72% | -$2.66M |
|
2769
Cogent Biosciences
COGT
$6.45B
| $1.03M | ﹤0.01% |
98,268
+80,227
| +445% | +$1.07M |
|
2770
Carpenter Technology
CRS
$24.3B
| $1.03M | ﹤0.01% |
21,452
+13,453
| +168% | +$633K |
|
2771
Schwab US Large- Cap ETF
SCHX
$74.5B
| $1.03M | ﹤0.01% |
+87,930
| New | +$1.01M |
|
2772
BlackRock Science and Technology Trust
BST
$1.76B
| $1.03M | ﹤0.01% |
32,189
+23,069
| +253% | +$746K |
|
2773
PUT
Stryker
SYK
$124B
| $1.03M | ﹤0.01% |
+5,000
| New | +$955K |
|
|
LUMO
2774
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.03M | ﹤0.01% |
77,141
+74,857
| +3,277% | +$1.13M |
|
|
ECOL
2775
DELISTED
US Ecology, Inc.
ECOL
| $1.03M | ﹤0.01% |
17,237
-26,331
| -60% | -$1.55M |
|
Similar funds
Israel Englander's Q2 2019 Portfolio in Review
As of Q2 2019, Israel Englander held 4,801 positions worth $66.5B, down 0.45% from $66.8B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
Israel Englander withdrew a net $3.96B in Q2 2019, closing 810 positions and reducing 1,571 holdings. Its most notable exit was Sysco, an estimated $208M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Israel Englander opened a new position in Moody's worth $125M.
- Israel Englander's largest Q2 2019 buy was Moody's: 638,271 shares worth $125M.
- Israel Englander added most to LyondellBasell Industries in Q2 2019, an estimated $492M increase.
- Israel Englander's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $568M.
- Israel Englander fully exited Sysco in Q2 2019, selling an estimated $208M.
- Israel Englander's ten largest holdings make up 7.7% of its $66.5B portfolio in Q2 2019.
- Israel Englander opened 865 new positions and closed 810 in Q2 2019.
- Israel Englander's portfolio value fell 0.45% quarter-over-quarter to $66.5B.
Based on Millennium Management's 13F filing for Q2 2019, filed 14 Aug 2019.